Bml Capital Management, LLC Connect Biopharma Holdings LTD Transaction History
Bml Capital Management, LLC
- $170 Billion
- Q3 2024
A detailed history of Bml Capital Management, LLC transactions in Connect Biopharma Holdings LTD stock. As of the latest transaction made, Bml Capital Management, LLC holds 2,093,232 shares of CNTB stock, worth $2.03 Million. This represents 1.77% of its overall portfolio holdings.
Number of Shares
2,093,232
Previous 2,043,248
2.45%
Holding current value
$2.03 Million
Previous $3.11 Billion
2.95%
% of portfolio
1.77%
Previous 2.22%
Shares
4 transactions
Others Institutions Holding CNTB
# of Institutions
12Shares Held
3.05MCall Options Held
0Put Options Held
0-
Ubs Oconnor LLC Chicago, IL511KShares$495,3790.05% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny176KShares$170,2350.0% of portfolio
-
Black Rock Inc. New York, NY104KShares$100,7740.0% of portfolio
-
Callan Capital, LLC La Jolla, CA41.8KShares$40,5680.0% of portfolio
-
Keudell33.5KShares$32,4460.01% of portfolio
About Connect Biopharma Holdings Ltd
- Ticker CNTB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,015,800
- Market Cap $53.4M
- Description
- Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for t...